NCT06466616

Brief Summary

The aim of this study is to evaluate the efficacy of a combination treatment consisting of ESWT and stretching of different muscles in the lower body compared to ESWT treatment alone in patients with plantar fasciitis.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 10, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 20, 2024

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

2 months

First QC Date

June 10, 2024

Last Update Submit

June 22, 2024

Conditions

Keywords

shockwave therapystretchingpaindisabilityactivity limitation

Outcome Measures

Primary Outcomes (2)

  • Pain intenisty VAS

    To evaluate the difference in pain after the intervention. We are going to use the Visual Analogue Scale, being 0 the better result and 10 the worst possible.

    Baseline (week 0), 8 weeks after baseline, 3 months after intervention and 12 months after intervention

  • Pain intensity PSFP

    We are also to use the Pain Scale for Plantar Fasciitis in their section for pain measure. The minimum score is 0 (better) and the maximum 100 (worst).

    Baseline (week 0), 8 weeks after baseline, 3 months after intervention and 12 months after intervention

Secondary Outcomes (1)

  • Disability

    Baseline (week 0), 8 weeks after baseline, 3 months after intervention and 12 months after intervention

Other Outcomes (2)

  • Activity limitation FFI

    Baseline (week 0), 8 weeks after baseline, 3 months after intervention and 12 months after intervention

  • Activity limitation FAAM

    Baseline (week 0), 8 weeks after baseline, 3 months after intervention and 12 months after intervention

Study Arms (2)

Real Stretching

EXPERIMENTAL

This group is going to realize 3 sessions of ESWT plus an 8 weeks stretching program.

Other: Real stretching

Placebo Stretching

PLACEBO COMPARATOR

This group is going to realize 3 sessions of ESWT plus an 8 weeks placebo stretching program.

Other: Placebo stretching

Interventions

Aplying 3 sesions of ESWT in patients with plantar fasciitis in the zone of pain. Futhermore they are going to do a program of 8 weeks stretching of plantar fascia, gastrocnemius and hamstring muscle.

Also known as: Extracorporeal Shock Wave Threatment
Real Stretching

Aplying 3 sesions of ESWT in patients with plantar fasciitis in the zone of pain. Futhermore they are going to do a program of 8 weeks placebo stretching of plantar fascia, gastrocnemius and hamstring muscle.

Also known as: Extrecorporeal Shock Wave Threatment
Placebo Stretching

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of pain in the medial area of the sole of the foot lasting 3 or more months.
  • Being diagnosed with plantar fasciitis by one of the physical therapists participating in the study.
  • Have a pain level equal to or greater than 3 on the Visual Analogue Scale (VAS).

You may not qualify if:

  • Presence of bilateral plantar fasciitis.
  • Signs of neurological abnormalities.
  • Infections and malignant tumors.
  • History of presence of dysfunction in the lower extremity.
  • Pregnant women
  • Have been treated with shock waves in the previous 12 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alcalá, Faculty of Nursing and Physiotherapy

Alcalá de Henares, Madrid, 28805, Spain

Location

Related Publications (5)

  • Wang YC, Chen SJ, Huang PJ, Huang HT, Cheng YM, Shih CL. Efficacy of Different Energy Levels Used in Focused and Radial Extracorporeal Shockwave Therapy in the Treatment of Plantar Fasciitis: A Meta-Analysis of Randomized Placebo-Controlled Trials. J Clin Med. 2019 Sep 19;8(9):1497. doi: 10.3390/jcm8091497.

    PMID: 31546912BACKGROUND
  • Rhim HC, Kwon J, Park J, Borg-Stein J, Tenforde AS. A Systematic Review of Systematic Reviews on the Epidemiology, Evaluation, and Treatment of Plantar Fasciitis. Life (Basel). 2021 Nov 24;11(12):1287. doi: 10.3390/life11121287.

    PMID: 34947818BACKGROUND
  • Sweeting D, Parish B, Hooper L, Chester R. The effectiveness of manual stretching in the treatment of plantar heel pain: a systematic review. J Foot Ankle Res. 2011 Jun 25;4:19. doi: 10.1186/1757-1146-4-19.

    PMID: 21703003BACKGROUND
  • Rompe JD, Furia J, Cacchio A, Schmitz C, Maffulli N. Radial shock wave treatment alone is less efficient than radial shock wave treatment combined with tissue-specific plantar fascia-stretching in patients with chronic plantar heel pain. Int J Surg. 2015 Dec;24(Pt B):135-42. doi: 10.1016/j.ijsu.2015.04.082. Epub 2015 May 1.

    PMID: 25940060BACKGROUND
  • Boonchum H, Bovonsunthonchai S, Sinsurin K, Kunanusornchai W. Effect of a home-based stretching exercise on multi-segmental foot motion and clinical outcomes in patients with plantar fasciitis. J Musculoskelet Neuronal Interact. 2020 Sep 1;20(3):411-420.

    PMID: 32877978BACKGROUND

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Guillem Serrabassa Ureña, MSc

    University of Alcalá

    PRINCIPAL INVESTIGATOR
  • Tomás Gallego Izquierdo, PhD

    University of Alcalá

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 10, 2024

First Posted

June 20, 2024

Study Start

May 6, 2024

Primary Completion

July 1, 2024

Study Completion

July 1, 2025

Last Updated

June 25, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations